1h Free Analyst Time
The publisher has been monitoring the cardiac biomarkers market and is forecast to grow by $7880.86 mn during 2022-2027, accelerating at a CAGR of 12.6% during the forecast period. Our report on the cardiac biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of CVDs, growing geriatric population, and rising number of M&A and new product launches.
The publisher's cardiac biomarkers market is segmented as below:
By Technology
- Conventional laboratory testing
- POC testing
By Product
- Troponin
- BNP and NT-proBNP
- CK-MB
- Myoglobin
- Others
By End-user
- Hospitals
- clinics
- Diagnostic laboratories
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the cardiac biomarkers market covers the following areas:
- Cardiac biomarkers market sizing
- Cardiac biomarkers market forecast
- Cardiac biomarkers market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market by Geography
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
- Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary - Chart on Market Segmentation by End-user
- Exhibit 08: Executive Summary - Chart on Incremental Growth
- Exhibit 09: Executive Summary - Data Table on Incremental Growth
- Exhibit 10: Executive Summary - Chart on Vendor Market Positioning
2.1 Market ecosystem
- Exhibit 11: Parent market
- Exhibit 12: Market Characteristics
3.1 Market definition
- Exhibit 13: Offerings of vendors included in the market definition
- Exhibit 14: Market segments
3.4 Market outlook: Forecast for 2022-2027
- Exhibit 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4.1 Global cardiac biomarkers market 2017 - 2021
- Exhibit 19: Historic Market Size - Data Table on Global cardiac biomarkers market 2017 - 2021 ($ million)
- Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
- Exhibit 21: Historic Market Size - Product Segment 2017 - 2021 ($ million)
- Exhibit 22: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
- Exhibit 23: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
- Exhibit 24: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5.1 Five forces summary
- Exhibit 25: Five forces analysis - Comparison between 2022 and 2027
- Exhibit 26: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
- Exhibit 27: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
- Exhibit 28: Threat of new entrants - Impact of key factors in 2022 and 2027
- Exhibit 29: Threat of substitutes - Impact of key factors in 2022 and 2027
- Exhibit 30: Threat of rivalry - Impact of key factors in 2022 and 2027
- Exhibit 31: Chart on Market condition - Five forces 2022 and 2027
6.1 Market segments
- Exhibit 32: Chart on Technology - Market share 2022-2027 (%)
- Exhibit 33: Data Table on Technology - Market share 2022-2027 (%)
- Exhibit 34: Chart on Comparison by Technology
- Exhibit 35: Data Table on Comparison by Technology
- Exhibit 36: Chart on Conventional laboratory testing - Market size and forecast 2022-2027 ($ million)
- Exhibit 37: Data Table on Conventional laboratory testing - Market size and forecast 2022-2027 ($ million)
- Exhibit 38: Chart on Conventional laboratory testing - Year-over-year growth 2022-2027 (%)
- Exhibit 39: Data Table on Conventional laboratory testing - Year-over-year growth 2022-2027 (%)
- Exhibit 40: Chart on POC testing - Market size and forecast 2022-2027 ($ million)
- Exhibit 41: Data Table on POC testing - Market size and forecast 2022-2027 ($ million)
- Exhibit 42: Chart on POC testing - Year-over-year growth 2022-2027 (%)
- Exhibit 43: Data Table on POC testing - Year-over-year growth 2022-2027 (%)
- Exhibit 44: Market opportunity by Technology ($ million)
7.1 Market segments
- Exhibit 45: Chart on Product - Market share 2022-2027 (%)
- Exhibit 46: Data Table on Product - Market share 2022-2027 (%)
- Exhibit 47: Chart on Comparison by Product
- Exhibit 48: Data Table on Comparison by Product
- Exhibit 49: Chart on Troponin - Market size and forecast 2022-2027 ($ million)
- Exhibit 50: Data Table on Troponin - Market size and forecast 2022-2027 ($ million)
- Exhibit 51: Chart on Troponin - Year-over-year growth 2022-2027 (%)
- Exhibit 52: Data Table on Troponin - Year-over-year growth 2022-2027 (%)
- Exhibit 53: Chart on BNP and NT-proBNP - Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Data Table on BNP and NT-proBNP - Market size and forecast 2022-2027 ($ million)
- Exhibit 55: Chart on BNP and NT-proBNP - Year-over-year growth 2022-2027 (%)
- Exhibit 56: Data Table on BNP and NT-proBNP - Year-over-year growth 2022-2027 (%)
- Exhibit 57: Chart on CK-MB - Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Data Table on CK-MB - Market size and forecast 2022-2027 ($ million)
- Exhibit 59: Chart on CK-MB - Year-over-year growth 2022-2027 (%)
- Exhibit 60: Data Table on CK-MB - Year-over-year growth 2022-2027 (%)
- Exhibit 61: Chart on Myoglobin - Market size and forecast 2022-2027 ($ million)
- Exhibit 62: Data Table on Myoglobin - Market size and forecast 2022-2027 ($ million)
- Exhibit 63: Chart on Myoglobin - Year-over-year growth 2022-2027 (%)
- Exhibit 64: Data Table on Myoglobin - Year-over-year growth 2022-2027 (%)
- Exhibit 65: Chart on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 66: Data Table on Others - Market size and forecast 2022-2027 ($ million)
- Exhibit 67: Chart on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 68: Data Table on Others - Year-over-year growth 2022-2027 (%)
- Exhibit 69: Market opportunity by Product ($ million)
8.1 Market segments
- Exhibit 70: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 71: Data Table on End-user - Market share 2022-2027 (%)
- Exhibit 72: Chart on Comparison by End-user
- Exhibit 73: Data Table on Comparison by End-user
- Exhibit 74: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
- Exhibit 75: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
- Exhibit 77: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
- Exhibit 79: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
- Exhibit 81: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Market opportunity by End-user ($ million)
9.1 Customer landscape overview
- Exhibit 83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10.1 Geographic segmentation
- Exhibit 84: Chart on Market share by geography 2022-2027 (%)
- Exhibit 85: Data Table on Market share by geography 2022-2027 (%)
- Exhibit 86: Chart on Geographic comparison
- Exhibit 87: Data Table on Geographic comparison
- Exhibit 88: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 90: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 91: Data Table on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 94: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 95: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 98: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 99: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 102: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 103: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 104: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 105: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 106: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 107: Data Table on US - Year-over-year growth 2022-2027 (%)
- Exhibit 108: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 109: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 110: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 111: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 112: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 113: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 114: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 115: Data Table on China - Year-over-year growth 2022-2027 (%)
- Exhibit 116: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 117: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 118: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 119: Data Table on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 120: Chart on India - Market size and forecast 2022-2027 ($ million)
- Exhibit 121: Data Table on India - Market size and forecast 2022-2027 ($ million)
- Exhibit 122: Chart on India - Year-over-year growth 2022-2027 (%)
- Exhibit 123: Data Table on India - Year-over-year growth 2022-2027 (%)
- Exhibit 124: Market opportunity by geography ($ million)
11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
- Exhibit 125: Impact of drivers and challenges in 2022 and 2027
12 Vendor Landscape
12.1 Overview
12.2 Vendor landscape
- Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
- Exhibit 127: Overview on factors of disruption
- Exhibit 128: Impact of key risks on business
13.1 Vendors covered
- Exhibit 129: Vendors covered
- Exhibit 130: Matrix on vendor position and classification
- Exhibit 131: Abbott Laboratories - Overview
- Exhibit 132: Abbott Laboratories - Business segments
- Exhibit 133: Abbott Laboratories - Key news
- Exhibit 134: Abbott Laboratories - Key offerings
- Exhibit 135: Abbott Laboratories - Segment focus
- Exhibit 136: BG Medicine Inc. - Overview
- Exhibit 137: BG Medicine Inc. - Product/Service
- Exhibit 138: BG Medicine Inc. - Key offerings
- Exhibit 139: Bio Rad Laboratories Inc. - Overview
- Exhibit 140: Bio Rad Laboratories Inc. - Business segments
- Exhibit 141: Bio Rad Laboratories Inc. - Key news
- Exhibit 142: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 143: Bio Rad Laboratories Inc. - Segment focus
- Exhibit 144: bioMerieux SA - Overview
- Exhibit 145: bioMerieux SA - Product/Service
- Exhibit 146: bioMerieux SA - Key news
- Exhibit 147: bioMerieux SA - Key offerings
- Exhibit 148: Boditech Med Inc. - Overview
- Exhibit 149: Boditech Med Inc. - Key offerings
- Exhibit 150: Creative Diagnostics - Overview
- Exhibit 151: Creative Diagnostics - Product/Service
- Exhibit 152: Creative Diagnostics - Key offerings
- Exhibit 153: Diazyme Laboratories Inc. - Overview
- Exhibit 154: Diazyme Laboratories Inc. - Product/Service
- Exhibit 155: Diazyme Laboratories Inc. - Key offerings
- Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
- Exhibit 161: Lepu Medical Technology Beijing Co. Ltd. - Overview
- Exhibit 162: Lepu Medical Technology Beijing Co. Ltd. - Product/Service
- Exhibit 163: Lepu Medical Technology Beijing Co. Ltd. - Key offerings
- Exhibit 164: LifeSign LLC - Overview
- Exhibit 165: LifeSign LLC - Product/Service
- Exhibit 166: LifeSign LLC - Key offerings
- Exhibit 167: LSI Medience Corp. - Overview
- Exhibit 168: LSI Medience Corp. - Product/Service
- Exhibit 169: LSI Medience Corp. - Key offerings
- Exhibit 170: Randox Laboratories Ltd. - Overview
- Exhibit 171: Randox Laboratories Ltd. - Product/Service
- Exhibit 172: Randox Laboratories Ltd. - Key offerings
- Exhibit 173: Response Biomedical Corp. - Overview
- Exhibit 174: Response Biomedical Corp. - Product/Service
- Exhibit 175: Response Biomedical Corp. - Key offerings
- Exhibit 176: Siemens Healthineers AG - Overview
- Exhibit 177: Siemens Healthineers AG - Business segments
- Exhibit 178: Siemens Healthineers AG - Key news
- Exhibit 179: Siemens Healthineers AG - Key offerings
- Exhibit 180: Siemens Healthineers AG - Segment focus
- Exhibit 181: Signosis Inc. - Overview
- Exhibit 182: Signosis Inc. - Product/Service
- Exhibit 183: Signosis Inc. - Key offerings
14.1 Scope of the report
14.2 Inclusions and exclusions checklist
- Exhibit 184: Inclusions checklist
- Exhibit 185: Exclusions checklist
- Exhibit 186: Currency conversion rates for US$
- Exhibit 187: Research methodology
- Exhibit 188: Validation techniques employed for market sizing
- Exhibit 189: Information sources
- Exhibit 190: List of abbreviations
- investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 6: Executive Summary - Chart on Market Segmentation by Product
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Vendor Market Positioning
Exhibit 11: Parent market
Exhibit 12: Market Characteristics
Exhibit 13: Offerings of vendors included in the market definition
Exhibit 14: Market segments
Exhibit 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 19: Historic Market Size - Data Table on Global cardiac biomarkers market 2017 - 2021 ($ million)
Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
Exhibit 21: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibit 22: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibit 23: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibit 24: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibit 25: Five forces analysis - Comparison between 2022 and 2027
Exhibit 26: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibit 27: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibit 28: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibit 29: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibit 30: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibit 31: Chart on Market condition - Five forces 2022 and 2027
Exhibit 32: Chart on Technology - Market share 2022-2027 (%)
Exhibit 33: Data Table on Technology - Market share 2022-2027 (%)
Exhibit 34: Chart on Comparison by Technology
Exhibit 35: Data Table on Comparison by Technology
Exhibit 36: Chart on Conventional laboratory testing - Market size and forecast 2022-2027 ($ million)
Exhibit 37: Data Table on Conventional laboratory testing - Market size and forecast 2022-2027 ($ million)
Exhibit 38: Chart on Conventional laboratory testing - Year-over-year growth 2022-2027 (%)
Exhibit 39: Data Table on Conventional laboratory testing - Year-over-year growth 2022-2027 (%)
Exhibit 40: Chart on POC testing - Market size and forecast 2022-2027 ($ million)
Exhibit 41: Data Table on POC testing - Market size and forecast 2022-2027 ($ million)
Exhibit 42: Chart on POC testing - Year-over-year growth 2022-2027 (%)
Exhibit 43: Data Table on POC testing - Year-over-year growth 2022-2027 (%)
Exhibit 44: Market opportunity by Technology ($ million)
Exhibit 45: Chart on Product - Market share 2022-2027 (%)
Exhibit 46: Data Table on Product - Market share 2022-2027 (%)
Exhibit 47: Chart on Comparison by Product
Exhibit 48: Data Table on Comparison by Product
Exhibit 49: Chart on Troponin - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Data Table on Troponin - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Chart on Troponin - Year-over-year growth 2022-2027 (%)
Exhibit 52: Data Table on Troponin - Year-over-year growth 2022-2027 (%)
Exhibit 53: Chart on BNP and NT-proBNP - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Data Table on BNP and NT-proBNP - Market size and forecast 2022-2027 ($ million)
Exhibit 55: Chart on BNP and NT-proBNP - Year-over-year growth 2022-2027 (%)
Exhibit 56: Data Table on BNP and NT-proBNP - Year-over-year growth 2022-2027 (%)
Exhibit 57: Chart on CK-MB - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Data Table on CK-MB - Market size and forecast 2022-2027 ($ million)
Exhibit 59: Chart on CK-MB - Year-over-year growth 2022-2027 (%)
Exhibit 60: Data Table on CK-MB - Year-over-year growth 2022-2027 (%)
Exhibit 61: Chart on Myoglobin - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on Myoglobin - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on Myoglobin - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on Myoglobin - Year-over-year growth 2022-2027 (%)
Exhibit 65: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibit 69: Market opportunity by Product ($ million)
Exhibit 70: Chart on End-user - Market share 2022-2027 (%)
Exhibit 71: Data Table on End-user - Market share 2022-2027 (%)
Exhibit 72: Chart on Comparison by End-user
Exhibit 73: Data Table on Comparison by End-user
Exhibit 74: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibit 77: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibit 78: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 81: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 82: Market opportunity by End-user ($ million)
Exhibit 83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 84: Chart on Market share by geography 2022-2027 (%)
Exhibit 85: Data Table on Market share by geography 2022-2027 (%)
Exhibit 86: Chart on Geographic comparison
Exhibit 87: Data Table on Geographic comparison
Exhibit 88: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 91: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibit 92: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 95: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 96: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 99: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 100: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 103: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 104: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 107: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibit 108: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 110: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 111: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 112: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 113: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 114: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 115: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibit 116: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 117: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 118: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 119: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibit 120: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 121: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 122: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 123: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibit 124: Market opportunity by geography ($ million)
Exhibit 125: Impact of drivers and challenges in 2022 and 2027
Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
Exhibit 127: Overview on factors of disruption
Exhibit 128: Impact of key risks on business
Exhibit 129: Vendors covered
Exhibit 130: Matrix on vendor position and classification
Exhibit 131: Abbott Laboratories - Overview
Exhibit 132: Abbott Laboratories - Business segments
Exhibit 133: Abbott Laboratories - Key news
Exhibit 134: Abbott Laboratories - Key offerings
Exhibit 135: Abbott Laboratories - Segment focus
Exhibit 136: BG Medicine Inc. - Overview
Exhibit 137: BG Medicine Inc. - Product/Service
Exhibit 138: BG Medicine Inc. - Key offerings
Exhibit 139: Bio Rad Laboratories Inc. - Overview
Exhibit 140: Bio Rad Laboratories Inc. - Business segments
Exhibit 141: Bio Rad Laboratories Inc. - Key news
Exhibit 142: Bio Rad Laboratories Inc. - Key offerings
Exhibit 143: Bio Rad Laboratories Inc. - Segment focus
Exhibit 144: bioMerieux SA - Overview
Exhibit 145: bioMerieux SA - Product/Service
Exhibit 146: bioMerieux SA - Key news
Exhibit 147: bioMerieux SA - Key offerings
Exhibit 148: Boditech Med Inc. - Overview
Exhibit 149: Boditech Med Inc. - Key offerings
Exhibit 150: Creative Diagnostics - Overview
Exhibit 151: Creative Diagnostics - Product/Service
Exhibit 152: Creative Diagnostics - Key offerings
Exhibit 153: Diazyme Laboratories Inc. - Overview
Exhibit 154: Diazyme Laboratories Inc. - Product/Service
Exhibit 155: Diazyme Laboratories Inc. - Key offerings
Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 161: Lepu Medical Technology Beijing Co. Ltd. - Overview
Exhibit 162: Lepu Medical Technology Beijing Co. Ltd. - Product/Service
Exhibit 163: Lepu Medical Technology Beijing Co. Ltd. - Key offerings
Exhibit 164: LifeSign LLC - Overview
Exhibit 165: LifeSign LLC - Product/Service
Exhibit 166: LifeSign LLC - Key offerings
Exhibit 167: LSI Medience Corp. - Overview
Exhibit 168: LSI Medience Corp. - Product/Service
Exhibit 169: LSI Medience Corp. - Key offerings
Exhibit 170: Randox Laboratories Ltd. - Overview
Exhibit 171: Randox Laboratories Ltd. - Product/Service
Exhibit 172: Randox Laboratories Ltd. - Key offerings
Exhibit 173: Response Biomedical Corp. - Overview
Exhibit 174: Response Biomedical Corp. - Product/Service
Exhibit 175: Response Biomedical Corp. - Key offerings
Exhibit 176: Siemens Healthineers AG - Overview
Exhibit 177: Siemens Healthineers AG - Business segments
Exhibit 178: Siemens Healthineers AG - Key news
Exhibit 179: Siemens Healthineers AG - Key offerings
Exhibit 180: Siemens Healthineers AG - Segment focus
Exhibit 181: Signosis Inc. - Overview
Exhibit 182: Signosis Inc. - Product/Service
Exhibit 183: Signosis Inc. - Key offerings
Exhibit 184: Inclusions checklist
Exhibit 185: Exclusions checklist
Exhibit 186: Currency conversion rates for US$
Exhibit 187: Research methodology
Exhibit 188: Validation techniques employed for market sizing
Exhibit 189: Information sources
Exhibit 190: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global cardiac biomarkers market: Abbott Laboratories, Advanced ImmunoChemical Inc., BG Medicine Inc., Bio Rad Laboratories Inc., bioMerieux SA, Boditech Med Inc., Creative Diagnostics, Danaher Corp., Diazyme Laboratories Inc., F. Hoffmann La Roche Ltd., Lepu Medical Technology Beijing Co. Ltd., LifeSign LLC, LSI Medience Corp., Noavaran Payesh Aani Salamat. Co., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Response Biomedical Corp., Siemens Healthineers AG, Signosis Inc., AgPlus Diagnostics Ltd., and Tosoh Corp.Commenting on the report, an analyst from the researcher said: 'The latest trend gaining momentum in the market is increased focus on personalized medicine.'
According to the report, one of the major drivers for this market is the increasing prevalence of CVDs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Advanced ImmunoChemical Inc.
- BG Medicine Inc.
- Bio Rad Laboratories Inc.
- bioMerieux SA
- Boditech Med Inc.
- Creative Diagnostics
- Danaher Corp.
- Diazyme Laboratories Inc.
- F. Hoffmann La Roche Ltd.
- Lepu Medical Technology Beijing Co. Ltd.
- LifeSign LLC
- LSI Medience Corp.
- Noavaran Payesh Aani Salamat. Co.
- Oy Medix Biochemica Ab
- Randox Laboratories Ltd.
- Response Biomedical Corp.
- Siemens Healthineers AG
- Signosis Inc.
- AgPlus Diagnostics Ltd.
- Tosoh Corp.
